Iron Supplementation for Severe Anemia from Bleeding Peptic Ulcer
For a patient with severe anemia (hemoglobin <10 g/dL) due to bleeding peptic ulcer disease, intravenous iron should be the first-line treatment rather than oral ferrous sulfate, as oral iron is inadequate for severe anemia and may worsen gastrointestinal symptoms. 1
Route Selection Based on Severity
Intravenous Iron is Preferred for Severe Anemia
- Hemoglobin <10 g/dL mandates consideration of IV iron as first-line therapy 1
- IV iron delivers faster hemoglobin response, is more effective, and is better tolerated than oral iron in severe anemia 1
- Patients with active gastrointestinal bleeding and severe anemia require IV iron because oral absorption is insufficient to match ongoing losses 1
Oral Iron May Be Considered Only If:
- Hemoglobin is >10 g/dL (mild anemia) 1
- The bleeding source is controlled and no longer active 1
- Patient has no gastrointestinal symptoms or intolerance 1
Dosing Recommendations
If Using Oral Ferrous Sulfate (Only for Mild Cases)
- Dose: 50-100 mg elemental iron once daily 2
- This translates to ferrous sulfate 200 mg once daily (contains approximately 65 mg elemental iron) 1, 2
- Take on an empty stomach for maximum absorption 2
- Multiple daily doses increase side effects without improving absorption 2
Critical caveat: The traditional dosing of ferrous sulfate 200 mg three times daily (600 mg total) is outdated and causes unnecessary gastrointestinal side effects without additional benefit 1, 2
If Using Intravenous Iron (Recommended for Severe Anemia)
- Ferric carboxymaltose: 500-1000 mg per dose, can be given over 15 minutes 1
- Iron sucrose: 200-300 mg per treatment episode 1
- Total iron deficit calculation based on body weight and hemoglobin:
Timing and Administration
Oral Iron Timing
- Once daily dosing in the morning on an empty stomach 2
- Avoid food within 2 hours before or 1 hour after administration 2
- Consider adding vitamin C 250-500 mg to enhance absorption 2
- If gastrointestinal side effects occur, switch to alternate-day dosing rather than multiple daily doses 2
Intravenous Iron Timing
- Can be administered as single large doses (up to 1000 mg for ferric carboxymaltose) 1
- No test dose required for newer formulations (ferric carboxymaltose, iron isomaltoside) 1
- Avoid iron dextran due to anaphylaxis risk 1
Duration of Treatment
Active Treatment Phase
- Continue until hemoglobin normalizes (≥12 g/dL in women, ≥13 g/dL in men) 1, 2
- Expected hemoglobin rise: 1-2 g/dL within 3-4 weeks of treatment 1, 2
- Check hemoglobin at 2 weeks to assess response 2
- If hemoglobin fails to rise by at least 1 g/dL after 3-4 weeks, consider treatment failure 1, 2
Replenishment Phase
- Continue iron supplementation for 3 months after hemoglobin normalization to replenish iron stores 1, 2
- Target ferritin >100 μg/L to prevent rapid recurrence 1
- For IV iron, aim for post-treatment ferritin of 400 μg/L to prevent recurrence for 1-5 years 1
Monitoring Schedule
- Check hemoglobin every 3 months for the first year after correction 1
- Then monitor every 6-12 months thereafter 1
- Re-initiate treatment if ferritin drops below 100 μg/L or hemoglobin falls below normal 1
Critical Pitfalls to Avoid
Common Errors in Peptic Ulcer Bleeding
- Do not use oral iron as monotherapy in severe anemia (Hb <10 g/dL) - absorption is inadequate and may worsen gastric symptoms 1
- Failure to control the bleeding source before expecting iron supplementation to work 1
- Using excessive oral iron doses (>100 mg elemental iron daily) which only increases side effects 1, 2
Monitoring Failures
- Not checking hemoglobin at 2-4 weeks to identify treatment failure early 2
- Stopping iron too early (before 3 months post-normalization) leading to store depletion 1, 2
- Rapid recurrence of anemia may indicate ongoing occult bleeding requiring repeat endoscopy 1
Special Considerations for Peptic Ulcer Disease
- Achlorhydria from proton pump inhibitors may impair oral iron absorption 3
- Helicobacter pylori gastritis is associated with iron deficiency and treatment failure 3, 4
- Consider duodenal-release formulations if standard oral iron fails in the setting of gastric pathology 3
When to Escalate Therapy
Indications for IV Iron Despite Mild Anemia
- Intolerance to at least two oral iron preparations 1, 2
- No hemoglobin increase after 2 weeks of adequate oral therapy 1
- Ongoing blood loss exceeding absorption capacity 5
- Severe anemia-related fatigue despite hemoglobin >10 g/dL 1